66 related articles for article (PubMed ID: 18094323)
1. Comments on "Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis".
Di Serio C; Pellerito S; Tarantini F
J Pharmacol Exp Ther; 2008 Jan; 324(1):404-5; author reply 406-7. PubMed ID: 18094323
[No Abstract] [Full Text] [Related]
2. Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis.
Zania P; Kritikou S; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
J Pharmacol Exp Ther; 2006 Jul; 318(1):246-54. PubMed ID: 16595737
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism.
Di Serio C; Pellerito S; Duarte M; Massi D; Naldini A; Cirino G; Prudovsky I; Santucci M; Geppetti P; Marchionni N; Masotti G; Tarantini F
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):63-9. PubMed ID: 17577318
[TBL] [Abstract][Full Text] [Related]
4. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis.
Zania P; Gourni D; Aplin AC; Nicosia RF; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
J Pharmacol Exp Ther; 2009 Feb; 328(2):378-89. PubMed ID: 18988770
[TBL] [Abstract][Full Text] [Related]
5. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
6. Pyrrolo[2,3-α]carbazole derivatives as topoisomerase I inhibitors that affect viability of glioma and endothelial cells in vitro and angiogenesis in vivo.
Lampropoulou E; Manioudaki M; Fousteris M; Koutsourea A; Nikolaropoulos S; Papadimitriou E
Biomed Pharmacother; 2011 Jun; 65(3):142-50. PubMed ID: 21616631
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1.
Tsopanoglou NE; Maragoudakis ME
Semin Thromb Hemost; 2007 Oct; 33(7):680-7. PubMed ID: 18000795
[TBL] [Abstract][Full Text] [Related]
8. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells].
Yang F; He YL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):978-80. PubMed ID: 16864091
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
McGonigle JS; Giachelli CM; Scatena M
Angiogenesis; 2009; 12(1):35-46. PubMed ID: 19105036
[TBL] [Abstract][Full Text] [Related]
10. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
Watts VL; Motley ED
Exp Biol Med (Maywood); 2009 Feb; 234(2):132-9. PubMed ID: 19064940
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents.
Mabeta P; Pepper MS
Angiogenesis; 2009; 12(1):81-90. PubMed ID: 19214765
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.
Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D
Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535
[TBL] [Abstract][Full Text] [Related]
13. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells.
Kalishwaralal K; Banumathi E; Ram Kumar Pandian S; Deepak V; Muniyandi J; Eom SH; Gurunathan S
Colloids Surf B Biointerfaces; 2009 Oct; 73(1):51-7. PubMed ID: 19481908
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic effects of the fruit of Alpinia oxyphylla.
He ZH; Ge W; Yue GG; Lau CB; He MF; But PP
J Ethnopharmacol; 2010 Nov; 132(2):443-9. PubMed ID: 20723592
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.
Kern J; Bauer M; Rychli K; Wojta J; Ritsch A; Gastl G; Gunsilius E; Untergasser G
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):478-84. PubMed ID: 18187668
[TBL] [Abstract][Full Text] [Related]
16. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
17. Hybrids of 1-deoxynojirimycin and aryl-1,2,3-triazoles and biological studies related to angiogenesis.
Zhao Y; Zhou Y; O'Boyle KM; Murphy PV
Bioorg Med Chem; 2008 Jun; 16(12):6333-7. PubMed ID: 18504133
[TBL] [Abstract][Full Text] [Related]
18. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
19. Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis.
Scott AN; Hetheridge C; Reynolds AR; Nayak V; Hodivala-Dilke K; Mellor H
Angiogenesis; 2008; 11(4):337-46. PubMed ID: 18758974
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis.
Moser C; Schachtschneider P; Lang SA; Gaumann A; Mori A; Zimmermann J; Schlitt HJ; Geissler EK; Stoeltzing O
Eur J Cancer; 2008 Jul; 44(11):1577-86. PubMed ID: 18445520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]